Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changhong Zhao

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Therapeutic Advances in Medical Oncology|January 6, 2025
Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trialMing Gao, Xia Zhang, Huan Yan, et al.
Journal of Diabetes|May 15, 2014
Efficacy of metformin-based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short-term intensive insulin therapyQingfeng Cheng, Shumin Yang, Changhong Zhao, et al.
Materials Science & Engineering. C, Materials for Biological Applications|December 1, 2020
Evaluation of remodeling and regeneration of electrospun PCL/fibrin vascular grafts in vivoLiang Zhao, Xiafei Li, Lei Yang, et al.
The Plant Journal : for Cell and Molecular Biology|December 28, 2022
Marsdenia tenacissima genome reveals calcium adaptation and tenacissoside biosynthesisYanli Zhou, Wei Fan, Haoyue Zhang, et al.
Eclinicalmedicine|September 10, 2024
Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC): a phase II trialDawei Chen, Bing Zou, Butuo Li, et al.
Medcomm|July 29, 2025
Camrelizumab, an Anti-PD-1 Monoclonal Antibody, Plus Carboplatin and Nab-Paclitaxel as First-Line Setting for Extensive-Stage Small-Cell Lung Cancer: A Phase 2 Trial and Biomarker AnalysisJia Yu, Deyu Cai, Sha Zhao, et al.
Frontiers in Cardiovascular Medicine|May 15, 2026
Dual-balloon overlapping post-dilation for stent optimization in markedly dilated coronary arteryYan Wang, Mingjing Shao, Jie Zhang, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Therapeutic Advances in Medical Oncology|January 6, 2025
Efficacy and safety of camrelizumab plus famitinib in patients with previously treated non-small-cell lung cancer: a single-arm, phase II trialMing Gao, Xia Zhang, Huan Yan, et al.
Journal of Diabetes|May 15, 2014
Efficacy of metformin-based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short-term intensive insulin therapyQingfeng Cheng, Shumin Yang, Changhong Zhao, et al.
Materials Science & Engineering. C, Materials for Biological Applications|December 1, 2020
Evaluation of remodeling and regeneration of electrospun PCL/fibrin vascular grafts in vivoLiang Zhao, Xiafei Li, Lei Yang, et al.
The Plant Journal : for Cell and Molecular Biology|December 28, 2022
Marsdenia tenacissima genome reveals calcium adaptation and tenacissoside biosynthesisYanli Zhou, Wei Fan, Haoyue Zhang, et al.
Eclinicalmedicine|September 10, 2024
Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC): a phase II trialDawei Chen, Bing Zou, Butuo Li, et al.
Medcomm|July 29, 2025
Camrelizumab, an Anti-PD-1 Monoclonal Antibody, Plus Carboplatin and Nab-Paclitaxel as First-Line Setting for Extensive-Stage Small-Cell Lung Cancer: A Phase 2 Trial and Biomarker AnalysisJia Yu, Deyu Cai, Sha Zhao, et al.
Frontiers in Cardiovascular Medicine|May 15, 2026
Dual-balloon overlapping post-dilation for stent optimization in markedly dilated coronary arteryYan Wang, Mingjing Shao, Jie Zhang, et al.
Pageof 4